(Q43851436)

English

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.

scientific article published in January 2002

Statements

Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5. (English)
0 references
Markus Loeffler
Andreas Josting
Dirk Hasenclever
Jeremy Franklin
Eckhart Duehmke
Klaus-Peter Schalk
Hartmut Kirchner
Gottfried Doelken
Reinhold Munker
Richard Herrmann
Anna Paola Anselmo

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit